# Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)

> **NCT05114954** · NA · COMPLETED · sponsor: **Hangzhou Dinova EP Technology Co., Ltd** · enrollment: 158 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** CardioPulsesTM pulsed field ablation system

## Key facts

- **NCT ID:** NCT05114954
- **Lead sponsor:** Hangzhou Dinova EP Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-27
- **Primary completion:** 2022-06-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05114954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05114954, "Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05114954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*